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Abstract
Background: Colorectal cancer is a leading cause of cancer mortality. Screening can be effective but is
underutilized. System- or multi-level interventions could be effective at increasing screening, but most have been
implemented and evaluated in higher-resource settings such as health maintenance organizations. Given the
disparities evident for colorectal cancer and the potential for screening to improve outcomes, there is a need to
expand this work to include diverse settings, including those who treat economically disadvantaged patients. This
paper describes the study protocol for a trial designed to increase colorectal cancer screening in those ‘safety-net’
health centers that serve underinsured and uninsured patients. This trial was designed and is being implemented
using a community-based participatory approach.
Methods/design: We developed a practical clinical cluster-randomized controlled trial. We will recruit 16
community health centers to this trial. This systems-level intervention consists of a menu of evidence-based
implementation strategies for increasing colorectal cancer screening. Health centers in the intervention arm then
collaborate with the study team to tailor strategies to their own setting in order to maximize fit and acceptability.
Data are collected at the organizational level through interviews, and at the provider and patient levels through
surveys. Patients complete a survey about their healthcare and screening utilization at baseline, six months, and
twelve months.
Outcomes: The primary outcome is colorectal cancer screening by patient self-report, supplemented by a
chart-audit in a subsample of patients. Implementation outcomes informed by the Reach, Efficacy/Effectiveness,
Adoption, Implementation, and Maintenance (RE-AIM) conceptual framework will be measured at patient, provider,
and practice levels.
Discussion: Our study is one of the first to integrate community participatory strategies to a randomized controlled
trial in a healthcare setting. The multi-level approach will support the ability of the intervention to affect screening
through multiple avenues. The participatory approach will strengthen the chance that implementation strategies
will be maintained after study completion and, supports external validity by increasing health center interest and
willingness to participate.
Trial registration: NCT01299493
Keywords: Colon cancer, Healthcare disparities, Screening, Randomized controlled trial, Intervention studies,
Multi-level intervention, Implementation strategy, Community-based participatory research
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Background
Colorectal cancer (CRC) is a leading cause of cancer
death among men and women in the United States [1].
Many CRC deaths could be avoided through prevention
and early detection activities; early stage CRC is associ-
ated with excellent survival [1]. Routine screening for
CRC is recommended starting at age 50 years for adults
at average-risk; several different screening tests have
been found effective and are recommended at varying
intervals [2,3]. CRC is unique among cancers, because
screening is associated not only with early detection, but
with prevention [4]. Cancers can be averted through the
identification and removal of precancerous polyps. Yet,
colorectal screening is underutilized; at least 40% of age-
eligible U.S. adults are not adherent to current screening
guidelines [5,6]. This rate is lower than many other can-
cer screenings.
There are disparities in screening and survival from
CRC. Individuals who are lower income, underinsured or
uninsured, or are from a racial/ethnic minority are less
likely to get screened and more likely to be diagnosed at
later stages [1,7]. Uninsured patients fare worse than their
insured counterparts even when adjusting for stage at
diagnosis [7-12]. Given that CRC is a leading cancer diag-
nosis and disparately experienced, and that effective
prevention and early detection tools reduce mortality by
one-half but are under-utilized in routine primary care
settings [13,14], it is important to investigate the feasibility
and effectiveness of strategies to increase screening.
Interventions to increase CRC rates that are focused on
individual level factors have had only minimal to moderate
success in getting patients screened. While individual-
level strategies can be effective and have promise,
systems- or multi-level approaches have the potential to
reach a wider swath of the patient population and thus
may have more overall impact [15-18]. Such approaches
can set the stage to increase the likelihood of patient-
provider discussion about CRC screening as well as
increase the likelihood that screening is referred and com-
pleted. Most interventions have been tested in structured
and well-resourced settings [19-22]. In response to a
Request for Applications (CA 09–032) from the Na-
tional Cancer Institute requesting a randomized trial
using Community-Based Participatory Research (CBPR)
methods, we met with our Colon Cancer Community Ad-
visory Board (CAB) to identify needs and elicit preferences
and suggestions for study design and implementation.
Our objective in this study is to conduct a practical clin-
ical trial [23-27] to evaluate the viability and effectiveness
of evidence-based implementation strategies in commu-
nity health centers serving populations disparately affected
by CRC. To achieve our stated aims, we are developing,
implementing, and evaluating a systems-level intervention
aimed at increasing CRC screening. The long-term goal is
to reduce CRC disparities by developing sustainable and
disseminable implementation approaches that will effect-
ively promote informed decisions about CRC screening
across a variety of settings, particularly those considered
underserved. Our protocol is described below.
Methods
This delayed start cluster randomized controlled study is
designed as a ‘practical clinical trial’ [23-28]. As such, it is
designed to test the impact of an evidence-based interven-
tion under ‘real world’ conditions. Using a rolling recruit-
ment, community health centers (CHCs) are randomized
to either intervention or comparison (i.e., delayed inter-
vention). The primary outcome is CRC screening rates as
assessed by patient self-report. Other outcomes, such as
implementation fidelity and reach, will be evaluated
according to the Reach, Efficacy/Effectiveness, Adoption,
Implementation, and Maintenance (RE-AIM) conceptual
framework [29-33]. This study underwent review by the
Washington University Human Research Protection Of-
fice (IRB Protocol #201110005).
Role of community-based participatory research in
this study
Based on the RFA and the input from our CAB, we
designed this research to follow established CBPR princi-
ples, including acknowledging the community; fostering
co-learning and capacity building for all; building on
strengths and resources within the community; integrating
and achieving a balance of all partners; facilitating collab-
orative, equitable partnership in all phases of research; a
focus on local relevance and determinants of health; in-
volving partners and systems development in a cyclical
and iterative process; disseminating finding and know-
ledge gained to all partners and involving all partners in
the dissemination process; and planning for a long-term
process and commitment [34,35]. Key aspects of CBPR in-
corporated in this trial include collaborative partnership
during design, development, implementation, and evalu-
ation, an emphasis on local relevance, and a commitment
to long-term relationships and sustainability of interven-
tions. As such, the early outcomes and formative work in-
volved in this research inform the procedures used in the
latter activities. Partnered activities and decisions occur
throughout the trial. Our cancer center’s Program for the
Elimination of Cancer Disparities had an existing network
of community and clinical partners who formed our CAB
and helped facilitate the integration of CBPR into the pro-
posal development and planning.
Theoretical framework
In addition to applying CBPR principles, another goal of
our study was to incorporate a multi-level approach that
acknowledged practical factors related to implementa-
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tion across settings. We chose the RE-AIM framework
[29-33] as the guide for our measures selection and ana-
lysis plan. RE-AIM describes different components of
dissemination research and is useful for translating re-
search to practice and for conceptualizing the external
validity of a trial. The following RE-AIM concepts are in-
corporated into our measures and analyses: reach and
representativeness, differences in implementation be-
tween CHCs, adoption of the trial and of the various
evidence-based implementation strategies by CHCs and
providers, effectiveness of the overall intervention in in-
creasing screening, and maintenance of resultant strategy
changes after the end of data collection. The study aims
to reach patient, healthcare providers, and systems that
affect care and care provision.
Setting and participants
Community health centers
To be eligible, CHCs must serve mostly Medicaid, unin-
sured, or lower-income patients; be willing to be ran-
domized to intervention or comparison, and willing to
allow the research team access to CHC managers/direc-
tors, patients, and providers. Sites (n = 16) are recruited
on a rolling basis. We chose this approach in order to
better serve the sites’ timetables and availability, and to
tap on their enthusiasm for improving quality of care at
their sites. Recruiting all sites at the beginning of the
trial would force some CHCs to wait before the study
started at their site, risking dropout due to adminis-
trative turnover or emerging or competing needs of
the CHC.
There are over 30 CHCs in our metropolitan region.
CHCs were initially identified from amongst our existing
community partners. Next, we created a list of federally-
qualified CHCs and other known CHCs in our targeted
region, and approached them to assess interest. Where
possible, we start with a known contact; in other sites,
the health center Chief Executive Officer or Chief Med-
ical Officer is identified from websites. In all cases,
potential sites are emailed an Institutional Review Board-
approved invitation letter and study information sheet.
Follow-up is conducted by the study team via email and
telephone. In most cases, a combination of email, tele-
phone, and in-person contacts will be made before CHCs
formally agree to participate in the trial. With each CHC,
we conduct an organizational assessment upon entry and
exit into the survey. Additionally, CHC providers will an-
swer anonymous surveys at the start/end of the study
to assess their awareness and perception of the trial.
Organizational and provider surveys will help us evaluate
the RE-AIM constructs of reach, adoption, implementa-
tion, and maintenance. We will also be able to better
characterize the representativeness (external validity) of
our participating sites.
Patients
Although the intervention is delivered at the practice-
level, primary outcomes of CRC screening will be assessed
via self-report from patients. Patient surveys will inform
effectiveness and implementation (for example, if educa-
tional materials at the clinic reached patients).
A random sample of patients will be recruited from each
participating CHC for the survey. Inclusion criteria in-
clude: age ≥49, English-speaking, having contact informa-
tion listed in the medical record, and been seen at the
CHC within the last two years. Patients are recruited by
mailed invitation letter from the health center about the
study and giving them the opportunity to opt out. Study
team members will follow-up with all patients who do not
opt out. We will aim to collect baseline data from 100 to
110 respondents per clinic where possible. With 70 to
75% retention by 12 months, this will result in adequate
power to detect intervention effects. We recognize that
some sites may have smaller patient populations and that
retaining participants over the course of the 12-month
study may be harder when working with underserved pop-
ulations whose contact information may change during
the study period. However, restricting our sample to only
health centers with large or stable patient populations
would limit external validity.
The study team considered using chart reviews as the
primary outcome. However, given the strength of support
for the validity of self-reported CRC screening [36-39],
and the difficulty of chart reviews in low-resource settings
where electronic medical records may be harder to search,
requiring chart reviews would be a barrier to CHC partici-
pation and potentially decrease external validity. We will
use a chart audit on a subset of sites for further verifica-
tion of self-report in this population (see section entitled
Data collection – Patient-level data).
Intervention
The intervention consists of a menu of evidence-based
strategies for increasing CRC screening. There are several
evidence-based systems interventions to promote CRC
screening in primary care, but few [20] have been tested in
underserved populations or in real-world settings. We se-
lected the primary strategies that have evidence for their
effectiveness based on the CDC Community Guide to Pre-
ventive Services [40,41] and the American Cancer Society/
National Colorectal Cancer Roundtable Toolkit for physi-
cians [42,43]: routine patient reminders, provider re-
minders, provider feedback, and structural changes. These
changes can reach the multiple levels of patient care in-
cluding systems, providers, and patients. CHCs random-
ized to the intervention arm will be presented with the
standard ‘menu’ of implementation strategies and will be
able to select the strategies they wish to implement for in-
creasing screening. We will partner with individual sites
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to tailor these strategies into specific interventions that
are compatible with their site and perceived as offering ad-
vantage over current practices. Comparison CHCs will be
offered the menu of strategies at the end of the trial after
data collection has ended. All sites receive access to pa-
tient education materials.
We chose this ‘menu’ approach for several reasons: data
indicate that healthcare providers are more likely to ad-
here to an intervention if they helped design and select it
[44]; this approach allows sites to decide which strategies
are feasible, relevant, and sustainable in their context (e.g.,
provider feedback might be difficult in a CHC without
electronic records or with basic electronic systems; patient
reminders are challenging if patient contact information is
not reliable); offering choice enhances generalizability and
representativeness by encouraging more wide-spread par-
ticipation and buy-in by CHCs; and important to our
CBPR approach, our community and clinical partners
strongly felt that CHCs need to have an active role in
selecting the intervention, rather than being ‘told what to
do’ by the researchers.
Once decision makers and stakeholders at a HC are
identified, the study team will meet with them to discuss
their site’s challenges (and current practices) regarding
CRC screening, and discuss the general main implementa-
tion strategies (reminders, feedback, etc.). Through discus-
sion and consensus, the research team will then develop a
menu tailored to each site that is then presented back
to the same group for their final decisions. Additional
personnel from the CHC will be consulted as needed (e.g.,
Information Technology officers if a strategy involves the
electronic medical record; health center managers if strat-
egies are directed at patients, etc.).
Data collection
Our primary outcome will be CRC screening (percent of
patients up-to-date on CRC screening per the U.S. Pre-
ventive Services Guidelines [45]) based on a survey of pa-
tients age-eligible for screening at baseline, six months,
and twelve months. As we will describe, data are also col-
lected at the provider- and practice-level.
Patient-level data
The baseline survey will include: demographics, healthcare
utilization, medical home, cancer screening, literacy [46],
behavior intentions, barriers to CRC screening [47-49],
and knowledge about colon cancer. Standard measures
from national surveys are used as available. The six-
month and 12-month surveys include self-reported CRC
screening, healthcare utilization, and awareness of screen-
ing or educational efforts. CHCs may add site-specific
questions if they wish.
Recruitment for the patient survey
Procedures for patient recruitment will be finalized in col-
laboration with the participating sites. At most sites, the
research team will work with the CHC to randomly select
eligible patients and mail letters of invitation to potential
participants. Letters will have an opt-out option and will
be followed up by telephone. We expect that some sites
will not want to mail letters out due to privacy concerns.
In those cases, participants will be recruited in person at
the participating health center. We will track the type of
recruitment used and evaluate any potential impact or
differences.
General procedures for follow-up data collection
Follow-up data will be collected via telephone survey.
These call attempts will be made on multiple days at dif-
ferent times of the day. After approximately five call at-
tempts with no answer, or two voicemail messages, the
study staff will mail a letter stating that we are attempting
contact. About a week after the letter is mailed, we will at-
tempt one more ‘round’ of calls. Calling will continue until
attempts to reach the participant have been exhausted
(determination that there are no working telephone num-
bers), participants have completed the survey or declined
participation, or the participant is more than three weeks
past their survey due-date.
Chart review
Chart review procedures will be worked out with each
CHC, who can opt in or out of this review. We aim to re-
cruit at least 10 of our 16 CHCs to participate in the chart
review, recognizing that such a procedure is onerous for
CHCs without a flexible electronic medical record system.
Chart review data will be used to supplement and sup-
port the self-report findings. We aim to review 74 charts
per CHC.
Provider-level data
To understand how the implementation strategies (and
the study) are perceived by the people who work at the
health center and to assess whether strategies directed at
providers actually reached them, we will also conduct
brief, anonymous surveys of health center employees. Sur-
veys will be distributed at the start of the study and post-
intervention. In general, these questions will address
RE-AIM principles, including implementation, perceived
maintenance, feasibility, acceptability, but we may add
questions to the post-intervention survey based on experi-
ences and feedback during implementation. To maximize
response, this survey will be brief (one page) and can be
mailed in a pre-paid envelope, or faxed to a secure fax ma-
chine. For example, if a CHC chose to develop provider
reminders in their electronic record, the post-survey
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would ask if the provider had seen the reminder and what
they thought about it.
Practice-level data
We will conduct an organizational assessment by in-
terviewing clinic administrators in order to address reach,
implementation, and maintenance of the intervention and
implementation strategies. Interviews will be audiotaped
and transcribed, when the interviewee consents. This
semi-structured interview will cover: patient characteris-
tics, current efforts to promote CRC screening if any,
current CRC screening rates, current efforts to promote
other preventive care or disease management, perceived
need for change, preferred changes, and barriers to imple-
mentation. The research team will work with the CHC
data manager, if necessary, to access some of this informa-
tion. We will ask our initial contact at the health center to
recommend other persons with whom we should speak,
such as other level managers, chief operating officers,
medical directors, quality improvement personnel, or opi-
nion leaders within the practice. Data, when presented,
will be de-identified (both to individual and to health cen-
ter). Any characteristics that could be used to identify the
administrator or the health center/health system will be
masked or aggregated. Data will be used to inform the
intervention development, but may be analyzed later (e.g.,
to look at characteristics of CHCs that did or did not
change screening rates). We will aim to conduct at least
two interviews per participating site.
Retention of health centers and survey respondents
We will use multiple evidence-based methods to ma-
ximize retention. We do not anticipate site-level attrition
once a CHC is enrolled, because CHCs are entitled to pick
and choose which strategies they wish to implement and
the data collection burden on them (organizational assess-
ment and exit interview) is designed to be minimal. How-
ever, the participatory process can be burdensome and
time-consuming, or perceived burden could deter sites
from participation. Our procedures are designed to bal-
ance fidelity to CBPR with reducing ‘what we ask’ from
participating sites. CHCs are reimbursed financially for all
phases of the study, though this does not truly capture the
time they spend in a participatory approach.
Attrition among patient participants is a potential limi-
tation. We will apply best practices for retention [50-53]
and collect complete contact information at enrollment
(name, postal address. and at least two telephone num-
bers). Participants will be asked to list a secondary contact
person as a locator. Differential attrition in the patient sur-
vey by study arm is unlikely because the intervention is at
the center-level and sites are randomized.
We expect some attrition amongst health center em-
ployees, more so due to turnover within CHCs than
because of the study. Our post-survey will ask how long
the respondent has been at the health center, but because
these surveys are not identifiable and not linked, we will
not know whether the same people answered a staff sur-
vey at pre and post evaluation.
Outcomes and analysis
Our analysis will examine rates of being up-to-date on
CRC screening, accounting for the clustered nature of
the data. We will also assess which CHCs were reached
by the study (and how representative they are of area
CHCs), reach of the intervention within a CHC (who was
‘touched’ by the intervention, which strategies were
adopted, implementation of strategies, and maintenance
of the strategies by analysis of our organizational assess-
ments, staff surveys, and qualitative feedback.
Power
This study was powered based on patient self-report of
screening. With16 CHCs (n = 74 participants per cluster)
and intra-class correlation at 0.04, we will have 80% power
to detect a 15% point difference in screening between
intervention and comparison. Prevalence rates are esti-
mated based on our experiences with similar patient pop-
ulations, local BRFSS data, and published screening rates.
Intervention effects were estimated from the rough aver-
age of published percent increases in screening for our po-
tential strategies. These strategies resulted in a range of 12
to 18 percentage point differences [54-64]. If intra-class
correlation is higher but the impact is greater, we still
maintain at least 80% power with this sample.
Analysis
Descriptive analysis will be used to characterize reach, ex-
ternal validity, adoption of strategies, and fidelity to imple-
mentation. Effectiveness of the intervention in increasing
CRC screening will focus on self-reported patient comple-
tion of CRC screening at 12 months post-baseline. Statis-
tical analysis will quantify the intervention effect at the
cluster (CHC) and individual (patient) levels. For the
individual-level analysis, we will use a generalized linear
mixed model, adjusting for individual-level covariates, and
cluster-level covariates, and accounting for the clustered
nature of the data. Confounders will be identified as those
variables that might influence the outcome and their asso-
ciation will be tested in a bivariate model. Variables that
are significantly associated with the outcome will be in-
cluded as potential covariates in the final adjusted model.
Trial status
The trial is currently ongoing. The first set of health
centers have been recruited and patient data collection
has begun.
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Discussion
Increasingly, researchers are trying to balance random-
ized controlled research with community-based research
aimed at decreasing disparities. Our research design is
aimed at testing the effect of an implementation in-
tervention to increase colorectal cancer screening, and at
the same time assess the viability (and challenge) of
translating evidence-based strategies into diverse settings.
The implementation of interventions at the practice-level
should mean that patients at the CHC have equal chance
to be exposed to an intervention if and when they come
for an appointment; other approaches that require pa-
tient uptake might disproportionately reach select groups
of patients.
Our approach to health center recruitment will allow us
to examine whether settings are representative, including
examining reach and adoption (two key elements of the
RE-AIM theoretical framework) by tracking how many
settings were approached, how many participated, and
reasons for non-participation [65-68]. The assessment of
participation and reasons for non-participation is a critical
advancement toward scientific rigor.
Our decision for allowing a ‘menu’ of implementation
strategies balances the ability to test intervention effects
with a respect for the different contexts and preferences of
each health center. We recognize that this approach is both
a strength and a challenge in the current study. The chal-
lenge in our ‘menu’ design is that it will be difficult to
know which strategy had impact, because CHCs can
choose as few or as many as they want. However, our main
question is whether the intervention approach of offering a
menu of strategies is effective. Identifying the specific effect
size of each individual strategy is secondary to the question
of whether the overall approach can increase screening.
We will carefully track organizational characteristics as
well as which strategies are adopted and implemented by
which CHCs. We plan to explore the differential effective-
ness of strategies if there is enough variation. For these rea-
sons, the menu approach strengthens our study and better
informs both the literature and prevention practice.
Efforts at reducing disparities and increasing use of ap-
propriate and recommended cancer screening must ad-
dress the varying contexts in which primary care occurs
and the many barriers to screening at the patient, pro-
vider, and clinic levels. Practical trials that address exter-
nal validity, and strive to understand how interventions
may (or may not) work in real-world settings are critical
to reducing and ultimately eliminating disparities in can-
cer screening and survival [65-68].
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